Feature

China’s biopharma industry: Between innovation and dependence

Share
Copied!

Published: April 22nd, 2025,
Last updated: April 23rd, 2025

Workers check glass ampoules at a pharmaceutical company in Jiangsu, China.
By

In biotechnology, China pursues a clearly strategically motivated course that goes beyond pure research funding. Since the mid-2000s, the sector has been „a fixture of China’s industrial policy“, emphasizes the latest report by the China think tank MERICS, which is exclusively available to Table.Briefings.

Sign up now and continue reading immediately

No credit card details required. No automatic renewal.

Share
Copied!
Trade Pharma EU Chamber of Commerce